首页> 外国专利> anordning foer at infoera medici (i roeda blodkroppar

anordning foer at infoera medici (i roeda blodkroppar

机译:告知医生的设备(在红血球中

摘要

PCT No. PCT/FR92/00623 Sec. 371 Date Jan. 3, 1994 Sec. 102(e) Date Jan. 3, 1994 PCT Filed Jul. 2, 1992 PCT Pub. No. WO93/00940 PCT Pub. Date Jan. 21, 1993An apparatus for incorporating one or more biologically active substances into red blood corpuscles (erythrocytes) by lysis and resealing technique comprises a washing unit, a lysis unit and a resealing unit. The washing unit obtains a suspension of erythrocytes from complete or incomplete blood. The lysis unit cools the erythrocyte suspension to a temperature below 10 DEG C. and maintains this temperature while the suspension is processed through a dialysis unit and subsequently exposed to the active substance. The treated erythrocyte suspension is held in a retardation pouch for a predetermined time and thereafter fed to the resealing unit, which heats the treated suspension to a temperature higher than 20 DEG C. and maintains this temperature while the treated suspension is exposed to the resealing product. The suspension exposed to the resealing product is collected in a collecting pouch for a predetermine period before it is discharged to the washing unit.
机译:PCT号PCT / FR92 / 00623秒371日期1994年1月3日102(e)日期,1994年1月3日,PCT,1992年7月2日,PCT公开。 WO93 / 00940 PCT公开号日期:1993年1月21日,一种通过裂解和再密封技术将一种或多种生物活性物质掺入红血球(红细胞)中的装置,该装置包括洗涤单元,裂解单元和再密封单元。洗涤单元从全血或不全血中获得红细胞的悬浮液。裂解单元将红细胞悬浮液冷却至低于10℃的温度,并保持该温度,同时该悬浮液通过透析单元进行处理并随后暴露于活性物质。将处理过的红细胞悬浮液在延迟袋中保持预定的时间,然后送至再密封单元,再加热处理过的悬浮液至高于20℃的温度,并保持该温度,同时使处理过的悬浮液暴露于再密封产品中。 。暴露在重新密封产品上的悬浮液在排放到清洗单元之前,要在预定的时间内收集在收集袋中。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号